Real ChatGPT answer · index seed9XUSRtFSnDwcompleteHealth and wellness · mental health and therapy servicescomparison
Evaluate the clinical differences between transcranial magnetic stimulation and traditional pharmacological interventions for treatment resistant persistent depressive symptoms.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Evaluate the clinical differences between transcranial magnetic stimulation and traditional pharmacological interventions for treatment resistant persistent depressive symptoms.
3 real searches · 1 real-search pass
clinical guidelines treatment resistant depression repetitive transcranial magnetic stimulation comparison pharmacotherapy efficacy safety 2024 2025Google ↗
OBSERVED
FDA transcranial magnetic stimulation depression indications treatment resistant depression contraindications adverse effects clinical evidenceGoogle ↗
OBSERVED
CANMAT guidelines treatment resistant depression rTMS pharmacological augmentation 2023Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
clinical guidelines treatment resistant depression repetitive transcranial magnetic stimulation comparison pharmacotherapy efficacy safety 2024 2025 Google ↗
FDA transcranial magnetic stimulation depression indications treatment resistant depression contraindications adverse effects clinical evidence Google ↗
CANMAT guidelines treatment resistant depression rTMS pharmacological augmentation 2023 Google ↗
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes · pmc.ncbi.nlm.nih.gov
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes · pmc.ncbi.nlm.nih.gov
- Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials · nature.com
- Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. · pubmed.ncbi.nlm.nih.gov
- Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology · doi.org
- Brain Stimulation Therapies · nimh.nih.gov
- Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology · doi.org
- Repetitive Transcranial Magnetic Stimulation (rTMS) Systems - Class II Special Controls Guidance for Industry and FDA Staff · fda.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
clinical guidelines treatment resistant depression repetitive transcranial magnetic stimulation comparison pharmacotherapy efficacy safety 2024 2025 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA transcranial magnetic stimulation depression indications treatment resistant depression contraindications adverse effects clinical evidence OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
CANMAT guidelines treatment resistant depression rTMS pharmacological augmentation 2023 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |